LYKA LABS
|
The Current P/S Ratio of LYKA LABS is 2.11.
| Share Price | ₹81.0 | Jan 06,2026 |
| Market Cap | ₹289.3 Cr | |
| Sales-TTM | ₹136.9 Cr | TTM-Consolidated Results |
| Price/Sales | 2.11x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹289.3 Cr] as on Jan 06,2026
(/) Sales [ ₹136.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.11x ]
Thus, for LYKA LABS , the investors are currently willing to pay '2.11 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !
The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LYKA LABS
PS Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.41x.
- LYKA LABS 's operated at median p/e ratio of 2.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2021 of 0.86x.
How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LYKA LABS | 136.9 | 2.11 | 289.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.68 | 422,319.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.59 | 176,383.0 |
| CIPLA LTD | 28,349.6 | 4.36 | 123,617.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.88 | 133,241.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.06 | 104,825.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.82 | 92,544.7 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.83 | 93,705.5 |
| LUPIN LTD | 24,750.7 | 3.97 | 98,300.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.20 | 71,537.3 |
| ABBOTT INDIA LTD | 6,714.4 | 9.00 | 60,411.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.11x |
| Max industry PS | 17.59x |
| Median industry PS | 4.36x |
| Average industry PS | 6.50x |
You may also like the below Video Courses